GoodRx (GDRX) Stock
Key stats
- Market cap
- $1.19B
- Price / Earnings ratio
- 78.1x
- EPS (TTM)
- $0.05
- Volume
- Loading
- 52-week high
- $3.89
- 52-week low
- $1.77
Source: third-party data provider, as of November 7, 2026
Compare with GDRX
Recent news
GoodRx Launches Employer Direct Weight Loss Offering
GoodRx Launches Employer Direct Weight Loss Offering
GDRX
Amazon, GoodRx target US prescription subscribers as health insurance coverage slips
Amazon, GoodRx target US prescription subscribers as health insurance coverage slips
GDRX
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GDRX
From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household
From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household
GDRXNews tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 50.40
- MACD 12/26/9
- 0.04
- EMA 9 of MACD
- 0.04
- MACD histogram
- 0.00
- SMA 50
- $3.44
- Price above SMA 50
- EMA 50
- $3.43
- Price above EMA 50
- SMA 200
- $2.84
- Price above SMA 200
- EMA 200
- $2.98
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.08 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news
GoodRx Launches Employer Direct Weight Loss Offering
GoodRx Launches Employer Direct Weight Loss Offering
GDRXAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
Amazon, GoodRx target US prescription subscribers as health insurance coverage slips
GDRXGoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GDRXFrom Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household
From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household
GDRX
Push for 'COMPETITIVE CASH PRICING': GoodRx CEO on TrumpRx partnership
Push for 'COMPETITIVE CASH PRICING': GoodRx CEO on TrumpRx partnership
GDRX
GoodRx Q2 Earnings Call Highlights
GoodRx Q2 Earnings Call Highlights
GDRX
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates
GDRX
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
GDRX
GoodRx Reports Second Quarter 2026 Results
GoodRx Reports Second Quarter 2026 Results
GDRX
GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
GDRXNews tone: automated (AI) classification of the article's content, not a price prediction.
About GoodRx
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Wendy Barnes | President, CEO & Director | 1973 |
| Mr. Justin Fengler | Chief Strategy & Operations Officer, CFO and Treasurer | 1988 |
| Mr. Douglas Joseph Hirsch | Co-founder & Director | 1971 |
| Mr. Thomas Chan | Chief Accounting Officer & Principal Accounting | 1986 |
| Mr. Nitin Shingate | Chief Technology Officer | — |
| Ms. Aubrey Reynolds | Director of Investor Relations | — |
| Ms. Gracye Cheng | Senior VP, General Counsel & Secretary | — |
| Ms. Vina M. Leite | Chief People Officer | 1970 |
| Mr. Scott Paul | Senior Vice President of Healthcare & Consumer Innovation | — |
| Mr. Aaron Crittenden | Chief Revenue Officer & President of Rx Marketplace | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 7, 2026
Technical indicators
- RSI 14
- 50.40
- MACD 12/26/9
- 0.04
- EMA 9 of MACD
- 0.04
- MACD histogram
- 0.00
- SMA 50
- $3.44
- Price above SMA 50
- EMA 50
- $3.43
- Price above EMA 50
- SMA 200
- $2.84
- Price above SMA 200
- EMA 200
- $2.98
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $3.75
- Average
- $4.55
- High
- $5.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -7.6 | -14.2 | ||||||||||
| 2022 | -26.0 | +3.6 | +15.5 | -31.1 | -42.0 | -21.2 | +1.1 | -3.0 | -18.1 | +9.1 | -18.0 | -9.7 |
| 2023 | +18.7 | -10.5 | +13.6 | -22.3 | +18.6 | +2.8 | +68.3 | -24.7 | -14.0 | -11.6 | +18.8 | +5.2 |
| 2024 | +6.8 | +27.1 | -15.0 | +0.0 | +12.9 | -3.1 | +15.7 | -9.7 | -11.7 | -11.7 | -21.8 | -6.1 |
| 2025 | +4.6 | +6.0 | -9.1 | +4.5 | -15.5 | +30.4 | -3.4 | -4.0 | -1.6 | -33.0 | -15.1 | -1.1 |
| 2026 | -17.5 | -18.0 | -9.7 | +17.4 | +14.5 | -6.5 | +0.3 | +10.4 | -4.9 | +6.7 | -1.7 |
